Choline Dihydrogen Citrate–Inositol–B-Vitamin Blend

Define your ingredient input

This group includes thiamine hydrochloride, riboflavin 5′-phosphate, nicotinic acid, niacinamide, pyridoxine hydrochloride, pyridoxal 5′-phosphate, methyltetrahydrofolic-acid glucosamine salt, methylcobalamin, d-biotin, d-calcium pantothenate, choline dihydrogen citrate and inositol. Request the riboflavin-phosphate salt and folate stereochemical/preparation details without assuming sodium or an L-prefix. Dicalcium phosphate and ascorbyl palmitate remain separately declared ancillary inputs, not additional named actives.

Discuss your procurement requirements

• Does the proposal retain all twelve named inputs, including choline dihydrogen citrate and inositol?
• Are nicotinic acid and niacinamide both declared separately, rather than replaced by one generic niacin entry?
• Are pyridoxine hydrochloride and pyridoxal 5′-phosphate both identified as separate preparations within the group?
• What salt identifies riboflavin 5′-phosphate, and what exact preparation and stereochemical declaration identify the methyltetrahydrofolic-acid glucosamine salt?
• How will choline dihydrogen citrate be distinguished from choline bitartrate without assuming those compounds are interchangeable?
• What relative composition and actual physical delivery form should be agreed without copying illustrative serving amounts?
• Which actual roles, preparations and inclusion declarations apply to the proposed ancillary context: Hypromellose/modified-cellulose shell context; Dicalcium phosphate; Ascorbyl palmitate as ancillary input; Microcrystalline cellulose; Silicon dioxide?
• Which identity, composition and other requested analytical methods and documents should support comparison of supplier proposals?
• What evaluation-sample quantity, handling, compatibility and storage questions should be agreed with the proposed supplier?
• What purchasing quantity in kg, intended formulation, destination and packaging requirements should be reviewed before commercial terms are agreed?

Confirm the offered specification, analytical methods, sample arrangements and documentation with the proposed supplier for your intended project.

Named ingredient composition

• Thiamine hydrochloride
• Riboflavin 5′-phosphate; salt not specified
• Nicotinic acid
• Niacinamide
• Pyridoxine hydrochloride
• Pyridoxal 5′-phosphate
• Methyltetrahydrofolic-acid glucosamine salt; stereochemistry to confirm
• Methylcobalamin
• d-Biotin
• d-Calcium pantothenate
• Choline dihydrogen citrate
• Inositol

Agree the complete proposed composition, ingredient roles and preparation details with the supplier. This list does not establish a supplied batch or specification.

Procurement questions and answers

Does the brief mean an amino-acid blend?

No. This declared composition is a B-vitamin/choline/inositol group, with the twelve named inputs retained explicitly. It does not add an unspecified amino-acid mixture.

Is riboflavin phosphate assumed to be its sodium salt?

No salt is assumed for this entry. Request the actual compound identity and distinguish it from preparations that explicitly declare sodium riboflavin phosphate.

Are ascorbyl palmitate and dicalcium phosphate extra actives?

They are kept in the ancillary declaration here. Ask the supplier to state their actual roles and quantities rather than silently promoting them into the twelve-input active group.

Formulation and procurement gallery

Related ingredient inputs

• Choline Dihydrogen Citrate — Compare the complete declared input groups and preparations; shared names do not establish equivalence.
• 5-MTHF Glucosamine Salt — Compare the complete declared input groups and preparations; shared names do not establish equivalence.
• Algal DHA–Methylfolate–Vitamin–Mineral Blend — Compare the complete declared input groups and preparations; shared names do not establish equivalence.